[PDF][PDF] Cilnidipine: next generation calcium channel blocker

MM Shete - J Assoc Physicians India, 2016 - researchgate.net
Hypertension is one of the most common conditions seen in primary care and a major public
health problem in India. It can lead to various complications if not detected early and treated …

[HTML][HTML] The fourth-generation Calcium channel blocker: Cilnidipine

KS Chandra, G Ramesh - Indian heart journal, 2013 - Elsevier
Several classes of antihypertensive agents have been in clinical use, including diuretics, α-
blockers, β-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 …

[HTML][HTML] Efficacy of cilnidipine (L/N-type calcium channel blocker) in treatment of hypertension: A meta-analysis of randomized and non-randomized controlled trials

RN Chakraborty, D Langade, S More, V Revandkar… - Cureus, 2021 - ncbi.nlm.nih.gov
Introduction: Hypertension is one of the most common cardiovascular diseases, and the
prevalence of hypertension continues to rise across the globe. National and international …

[PDF][PDF] Cilnidipine: Preclinical profile and clinical evaluation

H Uneyama, H Uchida, T Konda… - Cardiovascular drug …, 1999 - academia.edu
Cilnidipine (FRC-8653) is a dihydropyridine (DHP) type of calcium channel antagonist
originally developed in Japan. Unlike other calcium channel antagonists, cilnidipine blocks …

A Comprehensive Insight on Pharmacological Properties of Cilnidipine: A Fourth-generation Calcium Channel Blocker

R Kadian, A Nanda - Cardiovascular & Hematological Agents in …, 2024 - ingentaconnect.com
Preventing the development of cardiovascular problems is a key objective of
antihypertensive drugs. Many of the non-pressure related coronary risk factors for …

[PDF][PDF] Comparison of the effects of amlodipine and cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients

ZA Zaman, V Kumari - Int J Basic Clin Pharmacol, 2013 - Citeseer
Background: Hypertension is a widespread public health problem and a major risk factor.
Amlodipine, a calcium channel blocker is frequently used in the treatment of hypertension …

[PDF][PDF] Assessment of efficacy of amlodipine with cilnidipine in hypertensive patients: A comparative study

KA Babu - Int J Contemp Med Res, 2017 - researchgate.net
Introduction: The major problem encountered in treatment patients of hypertension and
diabtetic patients with hypertension is controlling their Systolic blood pressure (SBP) and …

Cilnidipine: A New Generation Ca2+ Channel Blocker with Inhibitory Action on Sympathetic Neurotransmitter Release

A Takahara - Cardiovascular therapeutics, 2009 - Wiley Online Library
Cilnidipine is a unique Ca2+ channel blocker with an inhibitory action on the sympathetic N‐
type Ca2+ channels, which is used for patients with hypertension in Japan. Cilnidipine has …

[PDF][PDF] A meta-analysis of the efficacy and safety of cilnidipine in Chinese patients with mild to moderate essential hypertension

X Guo-Liang, X Hui, W Hai-Di… - African Journal of …, 2012 - academicjournals.org
The purpose of this study was to evaluate the efficacy and safety of cilnidipine tablets to treat
Chinese patients with mild to moderate essential hypertension, and to examine the ability of …

Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure

S Hoshide, K Kario, J Ishikawa, K Eguchi… - Hypertension …, 2005 - nature.com
Cilnidipine is a novel and unique 1, 4-dydropyridine derivative calcium antagonist that
exerts potent inhibitory actions not only on L-type but also on N-type voltage-dependent …